Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    15475450 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase I/II Study of hLL1 in Multiple Myeloma
Conditions: Multiple Myeloma;   Myeloma, Plasma-Cell;   PLASMACYTOMA
Intervention: Biological: milatuzumab
2 Completed A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: hLL1-DOX (the doxorubicin conjugate of milatuzumab)

Study has passed its completion date and status has not been verified in more than two years.